Andrea Trevisan
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Recurrent Cervical HPV16 DNA Detection in Unvaccinated Women According to Presumed HPV16 Exposure Based on IgG and IgM Seroreactivity.
Journal: Journal of medical virology
Published: October 27, 2025
IgG and IgM Seroreactivity Against Natural HPV16 Infection and HLA-DRB1 and -DQB1 Polymorphism.
Journal: Journal of medical virology
Published: February 07, 2025
Systematic review and meta-analysis of the association between naturally induced IgG, IgM and neutralising antibodies to HPV16 and newly detected cervical HPV16 infection outcomes.
Journal: Sexually transmitted infections
Published: July 25, 2024
Naturally developed HPV16 antibodies and risk of newly detected cervical HPV infection outcomes.
Journal: Journal of medical virology
Published: December 06, 2023
Development and evaluation of a new non-competitive Luminex immunoassay detecting antibodies against human papillomavirus types 6, 11, 16 and 18.
Journal: The Journal of general virology
Published: May 27, 2021
Correlation between cervical HPV DNA detection and HPV16 seroreactivity measured with L1-only and L1+L2 viral capsid antigens.
Journal: Journal of medical microbiology
Published: June 09, 2020
Treatment Switch to Dolutegravir With 2 Nucleoside Reverse-Transcriptase Inhibitors (NRTI) in Comparison to Continuation With Protease Inhibitor/Ritonavir Among Patients With Human Immunodeficiency Virus at Risk for Prior NRTI Resistance: A Cohort Analysis of Real-World Data.
Journal: Open forum infectious diseases
Published: June 08, 2020
Antibodies to human papillomavirus types 6, 11, 16 and 18: Vertical transmission and clearance in children up to two years of age.
Journal: EClinicalMedicine
Published: November 29, 2019
The effect of a booster dose of quadrivalent or bivalent HPV vaccine when administered to girls previously vaccinated with two doses of quadrivalent HPV vaccine.
Journal: Human vaccines & immunotherapeutics
Published: February 26, 2015
Immunogenicity of quadrivalent HPV and combined hepatitis A and B vaccine when co-administered or administered one month apart to 9-10 year-old girls according to 0-6 month schedule.
Journal: Human vaccines & immunotherapeutics
Published: November 27, 2014
Determinants of baseline seroreactivity to human papillomavirus type 16 in the Ludwig-McGill cohort study.
Journal: BMC infectious diseases
Published: January 01, 2014
Human papillomavirus type 16 viral load measurement as a predictor of infection clearance.
Journal: The Journal of general virology
Published: May 17, 2013
Last Updated: 09/26/2026